Relaylit/Topics/CRISPR gene editing
Medicine

CRISPR gene editing

Prime editing, base editing, in vivo delivery, therapeutic applications.

Track crispr gene editing for free

CRISPR has diversified far beyond Cas9. Base editors, prime editors, CRISPR-Cas12/Cas13 and delivery mechanisms (LNPs, AAV engineering) are advancing in parallel. Relaylit tracks both foundational preprints (bioRxiv via Europe PMC) and peer-reviewed therapeutic applications.

Example brief

"CRISPR base and prime editing, focus on in vivo delivery for liver and CNS, last 12 months."

Paste this into your Relaylit profile and tweak. First digest arrives within hours.

Where Relaylit searches for this topic

PubMed

35M+ biomedical citations from MEDLINE, life-science journals, and online books.

About PubMed →

Europe PMC

42M+ life science citations, including preprints and full-text open-access papers.

About Europe PMC →

arXiv

2.4M+ preprints in physics, mathematics, computer science, and quantitative disciplines.

About arXiv →

Semantic Scholar

200M+ academic papers with citation graphs and AI-extracted metadata across disciplines.

About Semantic Scholar →

Related topics

Rare diseases research

Orphan indications, n=1 genomic medicine, gene therapy for small populations.

Read →

Ready to track this?

Your first crispr gene editing digest lands this week.

Start freeBrowse all topics